Epithelioid cell granulomas in chronic hepatitis C: Immunohistochemical character and histological marker of favourable response to interferon-α therapy

Histopathology

Volumn 33, Issue 3, 1998, Pages 216-221

  Harada, K ^a   Minato, H ^a   Hiramatsu, K ^a   Nakanuma, Y ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Chronic hepatitis C; Granuloma; Interferon

Indexed keywords

ALPHA INTERFERON; TUMOR MARKER;

ARTICLE; DISEASE ASSOCIATION; EPITHELIOID CELL; GRANULOMATOUS INFLAMMATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; MAJOR CLINICAL STUDY; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL;

ADULT; AGED; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; BIOPSY; FEMALE; GRANULOMA; HEPATITIS C, CHRONIC; HLA-DR ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON-ALPHA; LIVER DISEASES; MALE; MIDDLE AGED;

HEPATITIS C VIRUS;

EID: 0031690655     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1998.00497.x     Document Type: Article

References (21)

1. Denk H, Scheuer PJ, Baptista A et al. Guidelines for the diagnosis and interpretation of hepatic granulomas. Histopathology 1994; 25; 209-218.
2. McCluggage WG, Sloan JM. Hepatic granulomas in Northern Ireland: a thirteen year review. Histopathology 1994; 25; 219-228.
3. Nakanuma Y, Ohta G. Quantitation of hepatic granulomas and epithelioid cells in primary biliary cirrhosis. Hepatology 1983; 3; 423-427.
4. Nakanuma Y, Ohta G. Histometric and serial section observations of the intrahepatic bile ducts in primary biliary cirrhosis. Gastroenterology 1979; 76; 1326-1332.
5. Sherlock S. Disease of the Liver and Biliary System. Oxford: Blackwell Scientific Publications, 1989.
6. Hoso M, Nakanuma Y, Kawano M et al. Granulomatous cholangitis in chronic hepatitis C. a new diagnostic problem in liver pathology. Pathol. Int. 1996; 46; 301-305.
7. Attah EB. The presence of epithelioid granulomas in hepatitis C virus-related cirrhosis. Hum. Pathol. 1995; 26; 463-464.
8. Farges O, Bismuth H, Sebagh M, Reynes M. Granulomatous destruction of bile ducts after liver transplantation: primary biliary cirrhosis recurrence or hepatitis C virus infection? Hepatology 1995; 21; 1765-1767.
9. Emile JF, Sebagh M, Feray C, David F, Reynes M. The presence of epithelioid granulomas in hepatitis C virus-related cirrhosis. Hum. Pathol. 1993; 24; 1095-1097.
10. Yamamoto S, Iguchi Y, Ohomoto K et al. Epithelioid granuloma formation in type C chronic hepatitis: report of two cases. Hepatogastroenterology 1995; 42; 291-293.
11. Lefkowitch JH, Schiff ER, Davis GL et al. Pathological diagnosis of chronic hepatitis C. a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group. Gastroenterology 1993; 104; 595-603.
12. Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM. The pathology of hepatitis C. Hepatology 1992; 15; 567-571.
13. Dhillon AP, Dusheiko GM. Pathology of hepatitis C virus infection. Histopathology 1995; 26; 297-309.
14. Bach N, Thung SN, Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 1992; 15; 572-577.
15. Ludwig J, Czaja AJ, Dickson ER, LaRusso NF, Wiesner RH. Manifestations of nonsuppurative cholangitis in chronic hepatobiliary diseases: morphologic spectrum, clinical correlations and terminology. Liver 1984; 4; 105-116.
16. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19; 1513-1520.
17. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 1981; 29; 577-580.
18. Danque PO, Bach N, Schaffner F, Gerber MA, Thung SN. HLA-DR expression in bile duct damage in hepatitis C. Mod. Pathol. 1993; 6; 327-332.
19. Davis G, Balart L, Schiff E et al. Treatment of chronic hepatitis with recombinant interferon alpha: A multicenter randomized, controlled trial. N. Engl. J. Med. 1989; 321; 1501-1506.
20. Kaji K, Nakanuma Y, Harada K et al. Hemosiderin deposition in portal endothelial cells is a histologic marker predicting poor response to interferon-alpha therapy in chronic hepatitis C. Pathol. Int. 1991; 47; 347-352.
21. 2b therapy for chronic active hepatitis C. Dig. Dis. Sci. 1995; 40; 1226-1230.